title: [Liver transplantation in Norway through 25 years].
abstract: BACKGROUND
  In Norway, liver transplantation has been the treatment of choice for irreversible acute and chronic liver failure for 25 years. The aim of this article is to present a summary of the results obtained.
  
  
  METHODS
  All liver transplants performed in Norway in the period 25.02.84-31.12.08 have been reviewed retrospectively with respect to patient and donor epidemiology, survival and recurrence.
  
  
  RESULTS
  651 transplants have been performed in this period. The annual number of transplants increased gradually up to the year 2000 (31), and more steeply afterwards - to 79 in 2008. Also the number of organ donations has increased and reached 98 (20 pr. million inh.) in 2008. 5-year patient survival was 53 % in the period 1984-1994. In the period 2001-2008, 1-year survival was 90 % and 5-year survival was 83 %.
  
  
  CONCLUSIONS
  The gradual improvement of results should be interpreted in light of improvements within transplant surgery, medicine and anaesthesiology and the increased local experience due to the increasing number of transplants performed. The transplant centre at Rikshospitalet has developed into being among the largest of its kind within the Nordic Countries and the results compare well with the best international data.
authors.affiliation: Seksjon for transplantasjonskirurgi, Kirurgisk klinikk, Oslo universitetssykehus, Rikshospitalet, 0027 Oslo, Norway. tim.scholz@rikshospitalet.no
authors.forename: Tim
authors.initials: T
authors.lastname: Scholz
authors.forename: Tom H
authors.initials: TH
authors.lastname: Karlsen
authors.forename: Truls
authors.initials: T
authors.lastname: Sanengen
authors.forename: Erik
authors.initials: E
authors.lastname: Schrumpf
authors.forename: Pal Dag
authors.initials: PD
authors.lastname: Line
authors.forename: Kirsten Muri
authors.initials: KM
authors.lastname: Boberg
authors.forename: Pal Foyn
authors.initials: PF
authors.lastname: Jörgensen
authors.forename: Bjarte
authors.initials: B
authors.lastname: Fosby
authors.forename: Oystein
authors.initials: O
authors.lastname: Bentdal
authors.forename: Anniken Björnstad
authors.initials: AB
authors.lastname: Ostensen
authors.forename: Svein
authors.initials: S
authors.lastname: Osnes
authors.forename: Fridtjov
authors.initials: F
authors.lastname: Riddervold
authors.forename: Hakon
authors.initials: H
authors.lastname: Haugaa
authors.forename: Jon
authors.initials: J
authors.lastname: Hausken
authors.forename: Jon Bragi
authors.initials: JB
authors.lastname: Bergmann
authors.forename: Stein
authors.initials: S
authors.lastname: Foss
authors.forename: Kristian
authors.initials: K
authors.lastname: Björo
authors.forename: Aksel
authors.initials: A
authors.lastname: Foss
mesh_terms: D000293:Adolescent; D000328:Adult; D002648:Child; D002675:Child, Preschool; D049673:History, 20th Century; D049674:History, 21st Century; D006801:Humans; D007223:Infant; D017093:Liver Failure / Q000175:diagnosis / Q000601:surgery; D016031:Liver Transplantation / Q000266:history / Q000401:mortality / Q000706:statistics & numerical data; D008875:Middle Aged; D009664:Norway / Q000453:epidemiology; D012042:Registries; D012189:Retrospective Studies; D015996:Survival Rate; D014019:Tissue Donors; D014850:Waiting Lists; D055815:Young Adult